Rocket Lab Has Fallen 58% From Its High While Wall Street's Average Target Sits 79% Above the Price. One Side Is Badly Wrong.

Rocket Lab has crashed 58% from its $151 peak to $63.91, opening a stark gap with Wall Street's average price target of $114.33—79% above current trading levels. The divergence traces directly to the company's planned $8 billion acquisition of Iridium Communications, which demands a $3.6 billion bridge loan plus additional debt and equity financing that investors fear will strain the balance sheet.

The fundamentals tell a split story. Rocket Lab posted 63% revenue growth in Q1 and holds a $2.2 billion backlog, but the company generates only $680 million in annual revenue and remains unprofitable. Analyst consensus appears increasingly fragile: Piper Sandler's recent initiation carried an $83 target, 27% below the Street average and a tacit acknowledgment that the Iridium financing could weigh on shares longer than bulls anticipate.

The market is pricing execution risk on the deal structure. Either the stock is severely undervalued and the acquisition financing will clear without meaningful dilution, or Wall Street's targets are anchored to a pre-deal thesis that no longer holds.